These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31790576)
21. A comparative clinical evaluation of the assay of serum extracellular domain of HER2 protein using a chemiluminescent immunoassay method in breast cancer patients with or without HER2 protein expression in immunohistochemistry. Mokuyasu S; Suzuki Y; Seto T; Miyachi H; Tokuda Y Rinsho Byori; 2012 Jul; 60(7):612-20. PubMed ID: 22973719 [TBL] [Abstract][Full Text] [Related]
22. Dual-Modal Immunosensor with Functionalized Gold Nanoparticles for Ultrasensitive Detection of Chloroacetamide Herbicides. Zha Y; Lu S; Hu P; Ren H; Liu Z; Gao W; Zhao C; Li Y; Zhou Y ACS Appl Mater Interfaces; 2021 Feb; 13(5):6091-6098. PubMed ID: 33512133 [TBL] [Abstract][Full Text] [Related]
23. Preparation and application of immunoaffinity in-tube solid phase microextraction column with oriented antibody-immobilized porous layer open tubular capillary for high sensitive quantification of serum extracellular domain of human epidermal growth factor receptor 2 levels. Pan J; Song Y; Xu B; Liu J; Fu L; Xu L J Chromatogr A; 2020 May; 1619():460974. PubMed ID: 32087879 [TBL] [Abstract][Full Text] [Related]
24. Serum HER2/ECD value in stage I and II early breast cancer: need of a lower cut-off? Badzek S; Kelovic VL; Plestina S; Humar I; Veir Z; Mihaljevic Z Wien Klin Wochenschr; 2011 Dec; 123(23-24):726-31. PubMed ID: 22113445 [TBL] [Abstract][Full Text] [Related]
25. Carboxylic group riched graphene oxide based disposable electrochemical immunosensor for cancer biomarker detection. Rauf S; Mishra GK; Azhar J; Mishra RK; Goud KY; Nawaz MAH; Marty JL; Hayat A Anal Biochem; 2018 Mar; 545():13-19. PubMed ID: 29339058 [TBL] [Abstract][Full Text] [Related]
26. Immunoelectrochemical detection of the human epidermal growth factor receptor 2 (HER2) via gold nanoparticle-based rolling circle amplification. Shen C; Liu S; Li X; Zhao D; Yang M Mikrochim Acta; 2018 Nov; 185(12):547. PubMed ID: 30426312 [TBL] [Abstract][Full Text] [Related]
27. A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression. Reix N; Malina C; Chenard MP; Bellocq JP; Delpous S; Molière S; Sevrin A; Neuberger K; Tomasetto C; Mathelin C Breast Cancer Res Treat; 2016 Nov; 160(2):249-259. PubMed ID: 27709352 [TBL] [Abstract][Full Text] [Related]
28. Targeted FT-NIR and SERS Detection of Breast Cancer HER-II Biomarkers in Blood Serum Using PCB-Based Plasmonic Active Nanostructured Thin Film Label-Free Immunosensor Immobilized with Directional GNU-Conjugated Antibody. Khosroshahi ME; Patel Y; Umashanker V Sensors (Basel); 2024 Aug; 24(16):. PubMed ID: 39205071 [TBL] [Abstract][Full Text] [Related]
29. Sensitive determination of the human epidermal growth factor receptor 2 (HER2) by immuno-polymerase chain reaction with inductively coupled plasma-mass spectrometry detection. Asensio AF; Sierra LM; Montes-Bayón M; Blanco-González E Anal Chim Acta; 2019 Dec; 1090():39-46. PubMed ID: 31655644 [TBL] [Abstract][Full Text] [Related]
30. Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum. Qui S; Takeshita T; Sueta A; Tomiguchi M; Goto-Yamaguchi L; Hidaka K; Suzu I; Yamamoto Y; Iwase H Breast Cancer; 2021 May; 28(3):746-754. PubMed ID: 33538993 [TBL] [Abstract][Full Text] [Related]
31. Ultrasensitive and selective electrochemical diagnosis of breast cancer based on a hydrazine-Au nanoparticle-aptamer bioconjugate. Zhu Y; Chandra P; Shim YB Anal Chem; 2013 Jan; 85(2):1058-64. PubMed ID: 23215018 [TBL] [Abstract][Full Text] [Related]
32. Positive potential operation of a cathodic electrogenerated chemiluminescence immunosensor based on luminol and graphene for cancer biomarker detection. Xu S; Liu Y; Wang T; Li J Anal Chem; 2011 May; 83(10):3817-23. PubMed ID: 21513282 [TBL] [Abstract][Full Text] [Related]
33. Ultrasensitive immunoassay of carcinoma antigen 125 in untreated human plasma samples using gold nanoparticles with flower like morphology: A new platform in early stage diagnosis of ovarian cancer and efficient management. Hasanzadeh M; Sahmani R; Solhi E; Mokhtarzadeh A; Shadjou N; Mahboob S Int J Biol Macromol; 2018 Nov; 119():913-925. PubMed ID: 30081127 [TBL] [Abstract][Full Text] [Related]
34. A label-free multiplex electrochemical biosensor for the detection of three breast cancer biomarker proteins employing dye/metal ion-loaded and antibody-conjugated polyethyleneimine-gold nanoparticles. Kuntamung K; Jakmunee J; Ounnunkad K J Mater Chem B; 2021 Sep; 9(33):6576-6585. PubMed ID: 34279016 [TBL] [Abstract][Full Text] [Related]
35. Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients. Vazquez-Martin A; Fernandez-Real JM; Oliveras-Ferraros C; Navarrete JM; Martin-Castillo B; Del Barco S; Brunet J; Menendez JA Int J Oncol; 2009 Dec; 35(6):1369-76. PubMed ID: 19885560 [TBL] [Abstract][Full Text] [Related]
36. Sensitivity enhancement of an electrochemical immunosensor through the electrocatalysis of magnetic bead-supported non-enzymatic labels. Akter R; Kyun Rhee C; Rahman MA Biosens Bioelectron; 2014 Apr; 54():351-7. PubMed ID: 24292139 [TBL] [Abstract][Full Text] [Related]
37. Hybridization chain reaction assisted multicolor immunosensor for sensitively detection of human chorionic gonadotropin. Ma F; Zhao Z; Huang J; Xiong Q; Xu S; Lin Z Talanta; 2024 Apr; 270():125578. PubMed ID: 38150971 [TBL] [Abstract][Full Text] [Related]
38. Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer. Aurilio G; Sandri MT; Pruneri G; Zorzino L; Botteri E; Munzone E; Adamoli L; Facchi G; Cullurà D; Verri E; Rocca MC; Zurrida S; Iacovelli R; Nolè F Future Oncol; 2016 Sep; 12(17):2001-8. PubMed ID: 27255717 [TBL] [Abstract][Full Text] [Related]
39. An electrochemical immunosensor for detection of a breast cancer biomarker based on antiHER2-iron oxide nanoparticle bioconjugates. Emami M; Shamsipur M; Saber R; Irajirad R Analyst; 2014 Jun; 139(11):2858-66. PubMed ID: 24752767 [TBL] [Abstract][Full Text] [Related]
40. Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor. Pal M; Khan R Anal Biochem; 2017 Nov; 536():51-58. PubMed ID: 28789963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]